Potential Skin Cancer Breakthrough Tested at Scottsdale Healthcare Published Today in New England Journal of Medicine Sep 3, 2009
Dr. Von Hoff is an oncologist and chief scientific officer at the Virginia G. Piper Cancer Center at , physician-in-chief at Translational Genomics Research Institute (TGen) and chief scientific officer at US Oncology. The article appears online at NEJM.org and will be included in the Sept. 17 issue of New England Journal of Medicine. (PR Newswire)
Arizona Oncology opens second facility Aug 15, 2009
Arizona Oncology is affiliated with US Oncology, a network of more than 1,000 physicians nationwide treating more than 600,000 patients a year. Reader Comments. (Phoenix Business Journal, AZ)
US Oncology founder to retire Aug 7, 2009
R. Dale Ross, who founded US Oncology Holdings Inc. in 1992, is set to step down ... Bruce Broussard, US Oncology president and chief executive, will assume the chairman s title ... Almost seventeen years ago, I founded US Oncology with the mission of increasing access to and advancing the delivery of high-quality cancer care in America, Ross said. (Houston Business Journal, TX)
US Oncology Announces Retirement of R. Dale Ross and Appointment of Bruce Broussard as Chairman of the Board Aug 6, 2009
THE WOODLANDS, Texas, Aug. 5 /PRNewswire/ -- Today, the Board of Directors of US Oncology Holdings, Inc. and its wholly owned subsidiary, US Oncology, Inc. (collectively, "US Oncology" or the "Company"), announced that, effective Sept. 1, 2009, R. Dale Ross is retiring as Executive Chairman and from the Board of Directors ... "Almost seventeen years ago, I founded US Oncology with the mission of increasing access to and advancing the delivery of high-quality cancer care in America," said Ross... (PR Newswire)
US Oncology Research Network Participates in Phase III Follow-up Study to BiPar's Investigational Cancer Drug BSI-201 Jul 21, 2009
co-chair of the US Oncology Breast Cancer Research Committee, associate director for clinical research for and co-director of the Breast Cancer Research Program at and , a US Oncology affiliate in Dallas, Texas, will lead the study as a follow-up to the Phase II study presented in a plenary session at the 45th Annual Meeting of the held May 29-June 2, 2009, in Orlando, Fla ... "We expect that accrual will be very rapid within the US Oncology network and hope that this trial will lead to rapid... (PR Newswire)
New Debt Securities of US Oncology, Inc. Jun 6, 2009
Forward looking statements give our current expectations and projections relating to the financial condition, results of operations, plans, objectives, future performance and business of US Oncology, Inc. and its subsidiaries ... They can be affected by inaccurate assumptions we might make or by known or unknown risks and uncertainties, including those discussed under the heading "Risk Factors" in US Oncology Holdings, Inc. Annual Report on Form 10-K for the year ended December 31, 2008, and... (PR Newswire)
Caris Diagnostics Adds Leading Oncologist to Team of Personalized Medicine Experts May 28, 2009
He has served as Co-Chairman of the Breast Cancer Committee for the US Oncology (USO) Network and has been a practicing medical oncologist for over 18 years. In 2006, he was bestowed the Indiana Breast Cancer Alliance (IBCA) Medical Researcher ``Excellence'' Award and in 2007 was named the Indiana Breast Cancer Researcher of the Year by the Indiana Breast Cancer Coalition. (Primezone Releases)
US Oncology Commends Governor Sebelius' Confirmation as U.S. Secretary of Health and Human Services Apr 29, 2009
WASHINGTON, April 28 /PRNewswire-USNewswire/ -- US Oncology, which supports one of the nation's largest cancer treatment and research networks representing approximately 1,200 oncologists nationwide, applauds today's Senate confirmation of Kansas Governor Kathleen Sebelius as U.S. Secretary of Health and Human Services (HHS). "US Oncology is pleased to see Secretary Sebelius take the helm of national health care reform and push for new methods to address the current obstacles restricting access... (PR Newswire)
Personalized medicine helps cancer patients survive Apr 20, 2009
" In a significant number of patients, the targeted treatments provided significantly longer periods when tumors did not progress, or even shrunk, said Dr. Von Hoff, who also is a Medical Director of US Oncology and a former Director of the Arizona Cancer Center at the University of Arizona. Dr. Von Hoff said the new study was done in a way that avoided issues surrounding tumor subtypes and differences in individual biology, which have confounded other clinical trials. He said this clinical... (EurekAlert!)
Economic Downturn Forces Some Healthcare Facilities to Defer Capital Expenditures for Imaging Equipment Apr 11, 2009
Broadlane's clients include leading providers such as Advocate Health Care, Ascension Health, Beaumont Hospitals, CHRISTUS Health, Continuum Health Partners, Kaiser Permanente, Kindred Healthcare, MedCath Corporation, New Hanover Regional Medical Center, Sisters of Charity of Leavenworth Health System, Tenet Healthcare, The Health Alliance of Greater Cincinnati, US Oncology and UMass Memorial Health Care. The company is headquartered in Dallas with offices in Cincinnati, Detroit, Houston, New... (Primezone Releases)
New Corporate Agreement with Legacy Hospital Partners, Inc. Names Broadlane® Exclusive Provider of Supply Chain and Procurement Services Mar 17, 2009
External shift and agency management services Internal shift management, including electronic shift auctions Regional nurse float pool management and internal agency management E-commerce workforce exchange linking healthcare providers, clinical staff and agencies, enabling efficient shift management and fulfillment and reconciliation Broadlane's clients include leading providers such as Advocate Health Care, Ascension Health, Beaumont Hospitals, CHRISTUS Health, Continuum Health Partners,... (Yahoo News -- Press Releases)
